Journal Article Review Ahead of print 10 citations
PubMed: 39464604 DOI: 10.1039/d4sc04608k
Two in one: merging photoactivated chemotherapy and photodynamic therapy to fight cancer.
Chem Sci
Authors: Kirill M Kuznetsov, Kevin Cariou, Gilles Gasser
Affiliations
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology 75005 Paris France http://www.gassergroup.com/ +33 1 85 78 41 51.
Abstract
The growing number of cancer cases requires the development of new approaches for treatment. A therapy that has attracted the special attention of scientists is photodynamic therapy (PDT) due to its spatial and temporal resolution. However, it is accepted that this treatment methodology has limited application in cases of low cellular oxygenation, which is typical of cancerous tissues. Therefore, a strategy to overcome this drawback has been to combine this therapy with photoactivated chemotherapy (PACT), which works independently of the presence of oxygen. In this perspective, we examine compounds that act as both PDT and PACT agents and summarize their photophysical and biological characteristics.
MeSH
Photochemotherapy, Neoplasms, Drug Therapy, Therapeutics, Chemotherapy
Cited by
- The Combination of Active-Targeted Photodynamic Therapy and Photoactivated Chemotherapy for Enhanced Cancer Treatment. J Biophotonics, 2025
- Excited-State Cis and Trans Pt(IV) Diamine Anticancer Complexes. Inorg Chem, 2025
- Exploring the Phototherapeutic Applications of Mitochondria-Targeted COUPY Photocages of Antitumor Drugs. J Med Chem, 2025
- Phototoxicity of hydroxymethyl-BODIPYs: are photocages that innocent? Chem Sci, 2025
- A Near-Infrared-II Luminescent and Photoactive Vanadium(II) Complex with a 760 ns Excited State Lifetime. J Am Chem Soc, 2025